Viewing StudyNCT00232999



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00232999
Status: COMPLETED
Last Update Posted: 2021-11-12
First Post: 2005-10-04

Brief Title: EfficacySafety Study of Nebulized IVX-0142 a Novel Antiallergic Drug in Mild Allergic Asthma
Sponsor: Teva Branded Pharmaceutical Products RD Inc
Organization: Teva Branded Pharmaceutical Products RD Inc

Organization Data

Organization: Teva Branded Pharmaceutical Products RD Inc
Class: INDUSTRY
Study ID: IXR-201-04-142
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Teva Branded Pharmaceutical Products RD Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
AllerGen NCE Inc INDUSTRY